Speech Processing in Stuttering

July 15, 2026 updated by: Emily O'Dell Garnett, University of Michigan
This research is being done to better understand stuttering, specifically how people who stutter may process and/or produce speech. Eligible participants enrolled will complete a variety of computer and speech-based tasks on up to 2 visits.

Study Overview

Detailed Description

The study team will update the record to include the secondary identification number once the NIH has released the funds.

Study Type

Interventional

Enrollment (Actual)

145

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • University of Michigan
      • East Lansing, Michigan, United States, 48824
        • Michigan State University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 65 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria (adults who do not stutter):

  • 18-65 years old
  • English as primary language
  • Normal speech, language, hearing, cognition

Exclusion criteria: (adults who do not stutter)

  • Personal or family history of stuttering
  • Major medical or psychiatric illness

Inclusion criteria: (adults who stutter)

  • Aged 18-65 years
  • English as primary language
  • Normal speech, language, hearing, cognition (other than stuttering)
  • Currently stutters

Exclusion criteria: (adults who stutter)

  • Speech therapy within the past year
  • Major medical or psychiatric illness

Inclusion criteria: (children who do not stutter)

  • Aged 6 to 17 years
  • English as primary language
  • Normal speech, language, hearing, cognition

Exclusion criteria: (children who do not stutter)

  • Personal or family history of stuttering
  • Major medical or psychiatric illness
  • Language/motor delay

Inclusion criteria: (children who stutter)

  • Aged 6 to 17 years
  • English as primary language
  • Normal speech, language, hearing, cognition (other than stuttering)
  • Currently stutters

Exclusion criteria: (children who stutter)

  • Major medical or psychiatric illness
  • Language/motor delay

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Adults who stutter (AWS)
Participants will have 2 visits.
Participants will complete speech tasks such as listening to and/or producing speech and non-speech sounds.
Other: Healthy Adults
Participants will have 2 visits.
Participants will complete speech tasks such as listening to and/or producing speech and non-speech sounds.
Experimental: Children who Stutter
Participants will have 1 visit.
Participants will complete speech tasks such as listening to and/or producing speech and non-speech sounds.
Other: Healthy Children
Participants will have 1 visit.
Participants will complete speech tasks such as listening to and/or producing speech and non-speech sounds.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Phase Locking Value (PLV) - Session 1 Speech Tasks
Time Frame: Session 1 (up to 4 hours)

Participants will hear a series of single syllables spoken rhythmically and will be instructed to whisper the syllable "tah" repeatedly while the recording is playing.

The degree of synchronization (how well the participant's whispered syllables match the cadence of the recorded syllables they are listening to) will be measured by computing the PLV between subject's produced speech and the heard speech. The PLV is a vector with a value between 0 and 1 that reflects the phase difference between two signals, where 0 is a complete mis-match and a 1 is a perfect match. Adults were not instructed to attempt to match the cadence (Implicit task). Child participants were instructed to attempt to match the cadence (Explicit task).

Session 1 (up to 4 hours)
Phase Locking Value (PLV) - Session 2 Speech Tasks
Time Frame: Session 2 (up to 4 hours)

Adult participants will hear a series of single syllables spoken rhythmically and will be instructed to whisper the syllable "tah" repeatedly while the recording is playing. Child participants did not attend Session 2.

The degree of synchronization (how well the participant's whispered syllables match the cadence of the recorded syllables they are listening to) will be measured by computing the PLV between subject's produced speech and the heard speech. The PLV is a vector with a value between 0 and 1 that reflects the phase difference between two signals, where 0 is a complete mis-match and a 1 is a perfect match. Adults completed this task twice. For the first test, they were not instructed to attempt to match the cadence (Implicit task). For the second test, they were instructed to attempt to match the cadence (Explicit task).

Session 2 (up to 4 hours)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
R Statistic (Resultant Vector Length)
Time Frame: Session 1 (up to 4 hours)
In tapping synchronization (sensorimotor synchronization) research, the R statistic generally refers to the resultant vector length derived from circular statistics, used to quantify the consistency and stability of a participant's tapping relative to a rhythmic stimulus. It ranges from 0 to 1. 0=Complete inconsistency (taps are uniformly distributed). 1=Perfect consistency (all taps occur at the exact same relative phase).
Session 1 (up to 4 hours)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Emily Garnett, PhD, University of Michigan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 4, 2022

Primary Completion (Actual)

June 16, 2025

Study Completion (Actual)

June 16, 2025

Study Registration Dates

First Submitted

June 10, 2021

First Submitted That Met QC Criteria

June 10, 2021

First Posted (Actual)

June 18, 2021

Study Record Updates

Last Update Posted (Actual)

July 16, 2026

Last Update Submitted That Met QC Criteria

July 15, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe